IQVIA
IQV
$228.09
Share price
0.40%
Change (1 day)
13.26%
Change (1 year)
Earnings for IQVIA (IQV)
Earnings in 2023 (TTM): $2.13 B
According to IQVIA's latest financial reports the company's current earnings (TTM) are $2.13 B. In 2022 the company made an earning of $1.77 B an increase over its 2021 earnings that were of $1.50 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for IQVIA from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $2.13 B | 19.79% |
| 2022 | $1.77 B | 18.36% |
| 2021 | $1.50 B | 90.49% |
| 2020 | $0.78 B | -1.25% |
| 2019 | $0.79 B | 7.68% |
| 2018 | $0.74 B | 6.61% |
| 2017 | $0.69 B | 11.74% |
| 2016 | $0.62 B | -2.79% |
| 2015 | $0.64 B | 6.31% |
| 2014 | $0.60 B | 34.96% |
| 2013 | $0.44 B | 11.16% |
| 2012 | $0.40 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -100.10% | Bahamas |
 NRC Health
NRC | $40.82 M | -98.08% | 🇺🇸 USA |